In fact, a novel class of neuroleptics that is beneficial for ALS patients was identified using transgenic worms that express an aggregation-prone mutant form of TAR DNA-binding protein 43 (TDP-43) specifically in neurons (Patten et al. 2017). Here, TARDBP is linked to amyotrophic lateral sclerosis.